Healthcare in Japan: Access and Obstacles
28. 10., 16:00 bis 16:45
Taking the future into one’s own hands
Following the 1974 settlement, long-term support measures for Contergan/Thalidomide survivors were established in Japan, including the Ishizue Thalidomide Social Center. Since 2011, a research group funded by the Ministry of Health, Labour and Welfare has also been conducting health studies and preventive screenings.
Nevertheless, to this day, there is no systematic lifelong follow-up care and no continuous specialized medical care. Even within the general health insurance system, Contergan/Thalidomide survivors with unusual physical characteristics repeatedly encounter significant difficulties during standard examinations and treatments.
With increasing age and in the face of life-threatening illnesses, my conviction has grown that the existing system does not sufficiently protect our health and our lives. After a visit to Germany in 2024, we founded “One Team.” During this process, it became clear to us how important it is to exercise our rights.
The presentation highlights the challenges that Contergan/Thalidomide survivors in Japan face regarding access to healthcare. At the same time, it addresses our efforts to demand necessary research and medical care as our right and to actively help shape our own future.